Preserving function and quality of life after thyroid and parathyroid surgery

The Lancet Oncology

Volumn 9, Issue 11, 2008, Pages 1069-1075

  Adler, Joel T ^a   Sippel, Rebecca S ^a   Schaefer, Sarah ^a   Chen, Herbert ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHYROID AGENT; CALCIUM; RADIOACTIVE IODINE; THYROID HORMONE; VITAMIN D;

AUTOTRANSPLANTATION; CANCER SURVIVAL; CLINICAL FEATURE; COST EFFECTIVENESS ANALYSIS; COST OF ILLNESS; DISEASE SEVERITY; ELECTROSURGERY; ENDOCRINE SURGERY; GRAVES DISEASE; HEMATOMA; HOARSENESS; HUMAN; HYPERTHYROIDISM; HYPOCALCEMIA; HYPOTHYROIDISM; MINIMALLY INVASIVE SURGERY; NERVE INJURY; OPERATION DURATION; PARATHYROID DISEASE; PARATHYROIDECTOMY; PATIENT MONITORING; PATIENT SAFETY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; PREOPERATIVE EVALUATION; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; QUALITY OF LIFE; RECURRENT LARYNGEAL NERVE; REOPERATION; REVIEW; RISK REDUCTION; SECONDARY HYPERPARATHYROIDISM; SURGICAL APPROACH; SURGICAL RISK; SURGICAL TECHNIQUE; SURVIVAL TIME; THYROID ADENOMA; THYROID CANCER; THYROID DISEASE; THYROID SURGERY; THYROIDECTOMY; TREATMENT OUTCOME;

HEMATOMA; HOARSENESS; HUMANS; HYPERPARATHYROIDISM; HYPERTHYROIDISM; HYPOCALCEMIA; PARATHYROIDECTOMY; PATIENT SELECTION; QUALITY OF LIFE; SURGICAL PROCEDURES, MINIMALLY INVASIVE; THYROIDECTOMY;

EID: 54349098280     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(08)70276-6     Document Type: Review

References (74)

1. Welbourn R.B. The history of endocrine surgery (1990), Praeger, New York
2. Bhattacharyya N., and Fried M.P. Assessment of the morbidity and complications of total thyroidectomy. Arch Otolaryngol Head Neck Surg 128 (2002) 389-392
3. Sosa J.A., Bowman H.M., Tielsch J.M., Powe N.R., Gordon T.A., and Udelsman R. The importance of surgeon experience for clinical and economic outcomes from thyroidectomy. Ann Surg 228 (1998) 320-330
4. Moley J.F., Lairmore T.C., Doherty G.M., Brunt L.M., and DeBenedetti M.K. Preservation of the recurrent laryngeal nerves in thyroid and parathyroid reoperations. Surgery 126 (1999) 673-677
5. Affleck B.D., Swartz K., and Brennan J. Surgical considerations and controversies in thyroid and parathyroid surgery. Otolaryngol Clin North Am 36 (2003) 159-187
6. Hisham A.N., and Lukman M.R. Recurrent laryngeal nerve in thyroid surgery: a critical appraisal. ANZ J Surg 72 (2002) 887-889
7. Page C., Peltier J., Charlet L., Laude M., and Strunski V. Superior approach to the inferior laryngeal nerve in thyroid surgery: anatomy, surgical technique and indications. Surg Radiol Anat 28 (2006) 631-636
8. Mra Z., and Wax M.K. Nonrecurrent laryngeal nerves: anatomic considerations during thyroid and parathyroid surgery. Am J Otolaryngol 20 (1999) 91-95
9. Chen H. Radioguided parathyroid surgery. Adv Surg 38 (2004) 377-392
10. Marcus B., Edwards B., Yoo S., et al. Recurrent laryngeal nerve monitoring in thyroid and parathyroid surgery: the University of Michigan experience. Laryngoscope 113 (2003) 356-361
11. Randolph G.W., Kobler J.B., and Wilkins J. Recurrent laryngeal nerve identification and assessment during thyroid surgery: laryngeal palpation. World J Surg 28 (2004) 755-760
12. Dralle H., Sekulla C., Lorenz K., Brauckhoff M., and Machens A. Intraoperative monitoring of the recurrent laryngeal nerve in thyroid surgery. World J Surg 32 (2008) 358-360
13. Yarbrough D.E., Thompson G.B., Kasperbauer J.L., Harper C.M., and Grant C.S. Intraoperative electromyographic monitoring of the recurrent laryngeal nerve in reoperative thyroid and parathyroid surgery. Surgery 136 (2004) 1107-1115
14. Snyder S.K., and Hendricks J.C. Intraoperative neurophysiology testing of the recurrent laryngeal nerve: plaudits and pitfalls. Surgery 138 (2005) 1183-1191
15. Laccourreye O., Paczona R., Ageel M., Hans S., Brasnu D., and Crevier-Buchman L. Intracordal autologous fat injection for aspiration after recurrent laryngeal nerve paralysis. Eur Arch Otorhinolaryngol 256 (1999) 458-461
16. Spector B.C., Netterville J.L., Billante C., Clary J., Reinisch L., and Smith T.L. Quality-of-life assessment in patients with unilateral vocal cord paralysis. Otolaryngol Head Neck Surg 125 (2001) 176-182
17. Musholt T.J., Musholt P.B., Garm J., Napiontek U., and Keilmann A. Changes of the speaking and singing voice after thyroid or parathyroid surgery. Surgery 140 (2006) 978-988
18. Sakorafas G.H., Stafyla V., Bramis C., Kotsifopoulos N., Kolettis T., and Kassaras G. Incidental parathyroidectomy during thyroid surgery: an underappreciated complication of thyroidectomy. World J Surg 29 (2005) 1539-1543
19. Sippel R.S., Ozgul O., Hartig G.K., Mack E.A., and Chen H. Risks and consequences of incidental parathyroidectomy during thyroid resection. ANZ J Surg 77 (2007) 33-36
20. Abboud B., Sargi Z., Akkam M., and Sleilaty F. Risk factors for postthyroidectomy hypocalcemia. J Am Coll Surg 195 (2002) 456-461
21. Bohrer T., Hagemeister M., and Elert O. A clinical chameleon: postoperative hypoparathyroidism. Langenbecks Arch Surg 392 (2007) 423-426
22. Kikumori T., Imai T., Tanaka Y., Oiwa M., Mase T., and Funahashi H. Parathyroid autotransplantation with total thyroidectomy for thyroid carcinoma: long-term follow-up of grafted parathyroid function. Surgery 125 (1999) 504-508
23. Zedenius J., Wadstrom C., and Delbridge L. Routine autotransplantation of at least one parathyroid gland during total thyroidectomy may reduce permanent hypoparathyroidism to zero. ANZ J Surg 69 (1999) 794-797
24. Abbas G., Dubner S., and Heller K.S. Re-operation for bleeding after thyroidectomy and parathyroidectomy. Head Neck 23 (2001) 544-546
25. Pothier D.D. The use of drains following thyroid and parathyroid surgery: a meta-analysis. J Laryngol Otol 119 (2005) 669-671
26. Musunuru S., Schaefer S., and Chen H. The use of the Ligasure for hemostasis during thyroid lobectomy. Am J Surg 195 (2008) 382-384
27. Ware Jr. J.E., Kosinski M., Bayliss M.S., McHorney C.A., Rogers W.H., and Raczek A. Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: summary of results from the Medical Outcomes Study. Med Care 33 4 suppl (1995) AS264-AS279
28. Gulseren S., Gulseren L., Hekimsoy Z., Cetinay P., Ozen C., and Tokatlioglu B. Depression, anxiety, health-related quality of life, and disability in patients with overt and subclinical thyroid dysfunction. Arch Med Res 37 (2006) 133-139
29. Roman S., Boudourakis L., and Sosa J.A. Health services research in endocrine surgery. Curr Opin Oncol 20 (2008) 47-51
30. Vidal-Trecan G.M., Stahl J.E., and Durand-Zaleski I. Managing toxic thyroid adenoma: a cost-effectiveness analysis. Eur J Endocrinol 146 (2002) 283-294
31. Ljunggren J.G., Torring O., Wallin G., et al. Quality of life aspects and costs in treatment of Graves' hyperthyroidism with antithyroid drugs, surgery, or radioiodine: results from a prospective, randomized study. Thyroid 8 (1998) 653-659
32. Davies L., and Welch H.G. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA 295 (2006) 2164-2167
33. Chen H., Roberts J.R., Ball D.W., et al. Effective long-term palliation of symptomatic, incurable metastatic medullary thyroid cancer by operative resection. Ann Surg 227 (1998) 887-895
34. Schultz P.N., Stava C., and Vassilopoulou-Sellin R. Health profiles and quality of life of 518 survivors of thyroid cancer. Head Neck 25 (2003) 349-356
35. Bilimoria K.Y., Bentrem D.J., Ko C.Y., et al. Extent of surgery affects survival for papillary thyroid cancer. Ann Surg 246 (2007) 375-381
36. Shah M.D., Witterick I.J., Eski S.J., Pinto R., and Freeman J.L. Quality of life in patients undergoing thyroid surgery. J Otolaryngol 35 (2006) 209-215
37. Pasieka J.L., Parsons L.L., Demeure M.J., et al. Patient-based surgical outcome tool demonstrating alleviation of symptoms following parathyroidectomy in patients with primary hyperparathyroidism. World J Surg 26 (2002) 942-949
38. Mihai R., and Sadler G.P. Pasieka's parathyroid symptoms scores correlate with SF-36 scores in patients undergoing surgery for primary hyperparathyroidism. World J Surg 32 (2008) 807-814
39. Silverberg S.J., Shane E., Jacobs T.P., Siris E., and Bilezikian J.P. A 10-year prospective study of primary hyperparathyroidism with or without parathyroid surgery. N Engl J Med 341 (1999) 1249-1255
40. Quiros R.M., Alef M.J., Wilhelm S.M., Djuricin G., Loviscek K., and Prinz R.A. Health-related quality of life in hyperparathyroidism measurably improves after parathyroidectomy. Surgery 134 (2003) 675-681
41. Sheldon D.G., Lee F.T., Neil N.J., and Ryan Jr. J.A. Surgical treatment of hyperparathyroidism improves health-related quality of life. Arch Surg 137 (2002) 1022-1026
42. Burney R.E., Jones K.R., Coon J.W., Blewitt D.K., and Herm A.M. Assessment of patient outcomes after operation for primary hyperparathyroidism. Surgery 120 (1996) 1013-1018
43. Greutelaers B., Kullen K., Kollias J., et al. Pasieka Illness Questionnaire: its value in primary hyperparathyroidism. ANZ J Surg 74 (2004) 112-115
44. Edwards M.E., Rotramel A., Beyer T., et al. Improvement in the health-related quality-of-life symptoms of hyperparathyroidism is durable on long-term follow-up. Surgery 140 (2006) 655-663
45. Coker L.H., Rorie K., Cantley L., et al. Primary hyperparathyroidism, cognition, and health-related quality of life. Ann Surg 242 (2005) 642-650
46. Chen H., Mack E., and Starling J.R. Radioguided parathyroidectomy is equally effective for both adenomatous and hyperplastic glands. Ann Surg 238 (2003) 332-337
47. O'Connell D.A., Diamond C., Seikaly H., and Harris J.R. Objective and subjective scar aesthetics in minimal access vs conventional access parathyroidectomy and thyroidectomy surgical procedures: a paired cohort study. Arch Otolaryngol Head Neck Surg 134 (2008) 85-93
48. Politz D., Livingston C.D., Victor B., Askew R., and Jones L. Minimally invasive radio-guided parathyroidectomy in 152 consecutive patients with primary hyperparathyroidism. Endocr Pract 12 (2006) 630-634
49. Chen H., Sokoll L.J., and Udelsman R. Outpatient minimally invasive parathyroidectomy: a combination of sestamibi-SPECT localization, cervical block anesthesia, and intraoperative parathyroid hormone assay. Surgery 126 (1999) 1016-1021
50. Chen H., Mack E., and Starling J.R. A comprehensive evaluation of perioperative adjuncts during minimally invasive parathyroidectomy: which is most reliable?. Ann Surg 242 (2005) 375-380
51. Chen H., Pruhs Z., Starling J.R., and Mack E. Intraoperative parathyroid hormone testing improves cure rates in patients undergoing minimally invasive parathyroidectomy. Surgery 138 (2005) 583-587
52. Conrad D.N., Olson J.E., Hartwig H.M., Mack E., and Chen H. A prospective evaluation of novel methods to intraoperatively distinguish parathyroid tissue utilizing a parathyroid hormone assay. J Surg Res 133 (2006) 38-41
53. Haustein S.V., Mack E., Starling J.R., and Chen H. The role of intraoperative parathyroid hormone testing in patients with tertiary hyperparathyroidism after renal transplantation. Surgery 138 (2005) 1066-1071
54. Sippel R.S., Bianco J., Wilson M., et al. Can thallium-pertechnetate subtraction scanning play a role in the preoperative imaging for minimally invasive parathyroidectomy?. Clin Nucl Med 29 (2004) 21-26
55. Ito F., Sippel R., Lederman J., and Chen H. The utility of intraoperative bilateral internal jugular venous sampling with rapid parathyroid hormone testing. Ann Surg 245 (2007) 959-963
56. Lal A., and Chen H. The negative sestamibi scan: is a minimally invasive parathyroidectomy still possible?. Ann Surg Oncol 14 (2007) 2363-2366
57. Tang T., Dolan S., Robinson B., and Delbridge L. Does the surgical approach affect quality of life outcomes?-a comparison of minimally invasive parathyroidectomy with open parathyroidectomy. Int J Surg 5 (2007) 17-22
58. Adler J.T., Sippel R.S., and Chen H. The influence of surgical approach on quality of life after parathyroid surgery. Ann Surg Oncol 15 (2008) 1559-1565
59. Barczynski M., Cichon S., Konturek A., and Cichon W. Minimally invasive video-assisted parathyroidectomy versus open minimally invasive parathyroidectomy for a solitary parathyroid adenoma: a prospective, randomized, blinded trial. World J Surg 30 (2006) 721-731
60. Bilezikian J.P., Potts Jr. J.T., Gel H.F., et al. Summary statement from a workshop on asymptomatic primary hyperparathyroidism: a perspective for the 21st century. J Clin Endocrinol Metab 87 (2002) 5353-5361
61. Carneiro-Pla D.M., Irvin III G.L., and Chen H. Consequences of parathyroidectomy in patients with "mild" sporadic primary hyperparathyroidism. Surgery 142 (2007) 795-799
62. Bollerslev J., Jansson S., Mollerup C.L., et al. Medical observation, compared with parathyroidectomy, for asymptomatic primary hyperparathyroidism: a prospective, randomized trial. J Clin Endocrinol Metab 92 (2007) 1687-1692
63. Tsukahara K., Sugitani I., Fujimoto Y., and Kawabata K. Surgery did not improve the subjective neuropsychological symptoms of patients with incidentally detected mild primary hyperparathyroidism. Eur Arch Otorhinolaryngol 265 (2008) 565-569
64. Rao D.S., Phillips E.R., Divine G.W., and Talpos G.B. Randomized controlled clinical trial of surgery versus no surgery in patients with mild asymptomatic primary hyperparathyroidism. J Clin Endocrinol Metab 89 (2004) 5415-5422
65. Eigelberger M.S., Cheah W.K., Ituarte P.H., Streja L., Duh Q.Y., and Clark O.H. The NIH criteria for parathyroidectomy in asymptomatic primary hyperparathyroidism: are they too limited?. Ann Surg 239 (2004) 528-535
66. Talpos G.B., Bone III H.G., Kleerekoper M., et al. Randomized trial of parathyroidectomy in mild asymptomatic primary hyperparathyroidism: patient description and effects on the SF-36 health survey. Surgery 128 (2000) 1013-1020
67. Sejean K., Calmus S., Durand-Zaleski I., et al. Surgery versus medical follow-up in patients with asymptomatic primary hyperparathyroidism: a decision analysis. Eur J Endocrinol 153 (2005) 915-927
68. Zanocco K., Angelos P., and Sturgeon C. Cost-effectiveness analysis of parathyroidectomy for asymptomatic primary hyperparathyroidism. Surgery 140 (2006) 874-881
69. Pruhs Z.M., Starling J.R., Mack E., and Chen H. Changing trends for surgery in elderly patients with hyperparathyroidism at a single institution. J Surg Res 127 (2005) 58-62
70. Chiba Y., Satoh K., Ueda S., Kanazawa N., Tamura Y., and Horiuchi T. Marked improvement of psychiatric symptoms after parathyroidectomy in elderly primary hyperparathyroidism. Endocr J 54 (2007) 379-383
71. Egan K.R., Adler J.T., Olson J.E., and Chen H. Parathyroidectomy for primary hyperparathyroidism in octogenarians and nonagenarians: a risk-benefit analysis. J Surg Res 140 (2007) 194-198
72. Chen H., Parkerson S., and Udelsman R. Parathyroidectomy in the elderly: do the benefits outweigh the risks?. World J Surg 22 (1998) 531-535
73. Pasieka J.L., and Parsons L.L. A prospective surgical outcome study assessing the impact of parathyroidectomy on symptoms in patients with secondary and tertiary hyperparathyroidism. Surgery 128 (2000) 531-539
74. Chow K.M., Szeto C.C., Kum L.C., et al. Improved health-related quality of life and left ventricular hypertrophy among dialysis patients treated with parathyroidectomy. J Nephrol 16 (2003) 878-885